Related Experiment Video
Updated: Jun 20, 2026

10:38
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
Published on: February 1, 2020
Redefining resection margin status in pancreatic cancer
Caroline S Verbeke1, Krishna V Menon
1Department of Histopathology, St James's University Hospital, Leeds, UK. Caroline.Verbeke@leedsth.nhs.uk
Summary
Accurate pathological examination is vital for pancreatic cancer surgery outcomes. Underreporting of microscopic margin involvement (R1) leads to discrepancies in survival data and hinders effective treatment strategies.
Area of Science:
- Oncology
- Surgical Pathology
- Gastroenterology
Background:
- Curative resection is essential for pancreatic cancer survival.
- Standardized surgical procedures do not always achieve clear resection margins.
- Microscopic margin involvement (R1) rates vary significantly across studies.
Purpose of the Study:
- To review the variability in reported R1 rates in pancreatic cancer surgery.
- To investigate the reasons for incongruence between margin status and clinical outcomes.
- To highlight the impact of pathological reporting on patient survival data.
Main Methods:
- Literature review of studies reporting R1 rates in pancreatic cancer.
- Analysis of factors contributing to discrepancies in margin status reporting.
- Examination of the relationship between R1 status, recurrence, and survival.
Main Results:
- Reported R1 rates in pancreatic cancer surgery show marked variability.
- Frequent underreporting of microscopic margin involvement is identified as a key issue.
- Discrepancies between reported R1 status and actual patient outcomes (recurrence, survival) are common.
Conclusions:
- Lack of standardized pathological examination and definition of R1 contribute to variable reporting.
- Inconsistent reporting of microscopic margin involvement hinders accurate prognostic correlation.
- Improved standardization in pathology is crucial for reliable assessment of pancreatic cancer resection outcomes.
